Mi Wang
Assistant Research Scientist
Internal Medicine
[email protected]

Available to mentor

Mi Wang
Assistant Research Scientist
  • Recent Publications
  • Recent Publications See All Publications
    • Journal Article
      Discovery of SD-436: A Potent, Highly Selective and Efficacious STAT3 PROTAC Degrader Capable of Achieving Complete and Long-Lasting Tumor Regression.
      Xu R, Zhou H, Bai L, McEachern D, Wu D, Acharyya RK, Wang M, Tošović J, Yang C-Y, Chinnaswamy K, Meagher JL, Stuckey JA, Liu C, Wang M, Wen B, Sun D, Wang S. J Med Chem, 2024 Nov 28; 67 (22): 20495 - 20513. DOI:10.1021/acs.jmedchem.4c01946
      PMID: 39509603
    • Journal Article
      Discovery of CW-3308 as a Potent, Selective, and Orally Efficacious PROTAC Degrader of BRD9.
      Wang C, Wang M, Wang Y, Rej RK, Aguilar A, Xu T, Bai L, Tošović J, McEachern D, Li Q, Sarkari F, Wen B, Sun D, Wang S. J Med Chem, 2024 Aug 22; 67 (16): 14125 - 14154. DOI:10.1021/acs.jmedchem.4c00971
      PMID: 39132814
    • Journal Article
      Discovery of CBPD-268 as an Exceptionally Potent and Orally Efficacious CBP/p300 PROTAC Degrader Capable of Achieving Tumor Regression.
      Chen Z, Wang M, Wu D, Bai L, Xu T, Metwally H, Wang Y, McEachern D, Zhao L, Li R, Takyi-Williams J, Wang M, Wang L, Li Q, Wen B, Sun D, Wang S. J Med Chem, 2024 Apr 11; 67 (7): 5275 - 5304. DOI:10.1021/acs.jmedchem.3c02124
      PMID: 38477974
    • Journal Article
      Discovery of CBPD-409 as a Highly Potent, Selective, and Orally Efficacious CBP/p300 PROTAC Degrader for the Treatment of Advanced Prostate Cancer.
      Chen Z, Wang M, Wu D, Zhao L, Metwally H, Jiang W, Wang Y, Bai L, McEachern D, Luo J, Wang M, Li Q, Matvekas A, Wen B, Sun D, Chinnaiyan AM, Wang S. J Med Chem, 2024 Apr 11; 67 (7): 5351 - 5372. DOI:10.1021/acs.jmedchem.3c01789
      PMID: 38530938
    • Journal Article
      Discovery of AK-1690: A Potent and Highly Selective STAT6 PROTAC Degrader.
      Kaneshige A, Yang Y, Bai L, Wang M, Xu R, Mallik L, Chinnaswamy K, Metwally H, Wang Y, McEachern D, Tošović J, Yang C-Y, Kirchhoff PD, Meagher JL, Stuckey JA, Wang S. J Med Chem, 2024 Sep 23; DOI:10.1021/acs.jmedchem.4c01009
      PMID: 39311434
    • Journal Article
      Discovery of Potent, Highly Selective, and Efficacious SMARCA2 Degraders.
      Li Z, Harikrishnan LS, Xu G, Samanta D, Clemente JC, Leng L, Tu W, Yang L, Huang L, Wang M, Wang S, Deng Q, Behshad E, Nagilla R, Orth P, Rice C, Strickland C, Mohammad HP, Priestley ES, Sui Z. J Med Chem, 2024 Nov 21; DOI:10.1021/acs.jmedchem.4c01878
      PMID: 39570797
    • Journal Article
      Discovery of Pyrrolo[2,3-c]pyridines as Potent and Reversible LSD1 Inhibitors.
      Zheng C, Rej RK, Wang M, Huang L, Fernandez-Salas E, Yang C-Y, Wang S. ACS Med Chem Lett, 2023 Oct 12; 14 (10): 1389 - 1395. DOI:10.1021/acsmedchemlett.3c00292
      PMID: 37849536
    • Journal Article
      Discovery of ARD-1676 as a Highly Potent and Orally Efficacious AR PROTAC Degrader with a Broad Activity against AR Mutants for the Treatment of AR + Human Prostate Cancer.
      Xiang W, Zhao L, Han X, Xu T, Kregel S, Wang M, Miao B, Qin C, Wang M, McEachern D, Lu J, Bai L, Yang C-Y, Kirchhoff PD, Takyi-Williams J, Wang L, Wen B, Sun D, Ator M, Mckean R, Chinnaiyan AM, Wang S. J Med Chem, 2023 Sep 28; 66 (18): 13280 - 13303. DOI:10.1021/acs.jmedchem.3c01264
      PMID: 37683104